Whang H Y, Mayer H, Schmidt M G, Neter E
Infect Immun. 1976 Apr;13(4):1074-9. doi: 10.1128/iai.13.4.1074-1079.1976.
Certain polysaccharides have been shown to inhibit the antibody response of rabbits to the common enterobacterial antigen (CA). The present investigation revealed that striking differences exist in the immunosuppressive effects of enteric bacteria and their lipolysaccharides (lps), depending upon CA production by the strains. Mixtures of immunogenic strains (Escherichia coli F2378 [R4], E. coli F470 [R1], or Shigella boydii F3140 [R]) and non-immunogenic CA-producing strains, such as E. coli O1, E. coli O113, Salmonella montevideo, and S. minnesota, as well as the R mutants E. coli F614 (R1), E. coli F757 (R1), and S. typhimurium his 642 (Ra), failed to elicit CA antibodies. In contrast, mixtures of the immunogen and CA-negative strains S. typhimurium his 386 (Ra) and S. minnesota P595 (Re) or R555 (Ra) yielded antibodies in titers similar to those elicited by the immunogen alone. Further, LPS of CA-positive but not of CA-negative strains exerted this immunosuppressive effect. Quantitative studies revealed that LPS of S. minnesota in amounts of 100 mug/ml was strongly immunosuppressive, in amounts of 20 mug/ml slightly effective, and in amounts of 4 mug/ml ineffective. It is postulated that hitherto unknown differences exist, either in composition or in configuration, between LPS obtained from different microorganisms to account for the strain-related differences in immunosuppressive effects and, further, that the immunosuppressive LPS interacts with immunogenic CA.
某些多糖已被证明可抑制兔子对常见肠道细菌抗原(CA)的抗体反应。目前的研究表明,肠道细菌及其脂多糖(LPS)的免疫抑制作用存在显著差异,这取决于菌株产生CA的能力。免疫原性菌株(大肠杆菌F2378 [R4]、大肠杆菌F470 [R1]或鲍氏志贺菌F3140 [R])与非免疫原性CA产生菌株(如大肠杆菌O1、大肠杆菌O113、蒙得维的亚沙门氏菌和明尼苏达沙门氏菌)以及R突变体大肠杆菌F614(R1)、大肠杆菌F757(R1)和鼠伤寒沙门氏菌his 642(Ra)的混合物未能引发CA抗体。相反,免疫原与CA阴性菌株鼠伤寒沙门氏菌his 386(Ra)和明尼苏达沙门氏菌P595(Re)或R555(Ra)的混合物产生的抗体效价与单独免疫原引发的抗体效价相似。此外,CA阳性菌株而非CA阴性菌株的LPS具有这种免疫抑制作用。定量研究表明,100微克/毫升的明尼苏达沙门氏菌LPS具有强烈的免疫抑制作用,20微克/毫升的LPS作用稍弱,4微克/毫升的LPS则无作用。据推测,从不同微生物获得的LPS在组成或构型上存在迄今未知的差异,以解释免疫抑制作用中与菌株相关的差异,此外,免疫抑制性LPS与免疫原性CA相互作用。